Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.950
+0.050 (1.28%)
At close: Oct 9, 2025, 4:00 PM EDT
3.940
-0.010 (-0.25%)
After-hours: Oct 9, 2025, 4:10 PM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $502.53 million as of October 9, 2025. Its market cap has decreased by -26.37% in one year.
Market Cap
502.53M
Enterprise Value
262.92M
1-Year Change
-26.37%
Ranking
Category
Stock Price
$3.95
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $502.53M, a decrease of -77.77%. That is a compound annual growth rate of -30.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 496.17M | -40.65% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.88B |
| Johnson & Johnson | 460.19B |
| AbbVie | 407.53B |
| UnitedHealth Group | 333.01B |
| AstraZeneca | 266.87B |
| Novo Nordisk | 261.06B |
| Novartis AG | 256.06B |
| Abbott Laboratories | 232.02B |